BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34870469)

  • 1. A Systematic Review and Meta-Analysis on the Effects of Exercise on the Endocannabinoid System.
    Desai S; Borg B; Cuttler C; Crombie KM; Rabinak CA; Hill MN; Marusak HA
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):388-408. PubMed ID: 34870469
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating endocannabinoids and psychological outcomes in women with PTSD.
    Botsford C; Brellenthin AG; Cisler JM; Hillard CJ; Koltyn KF; Crombie KM
    J Anxiety Disord; 2023 Jan; 93():102656. PubMed ID: 36469982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress.
    Gowatch LC; Evanski JM; Ely SL; Zundel CG; Bhogal A; Carpenter C; Shampine MM; O'Mara E; Mazurka R; Barcelona J; Mayo LM; Marusak HA
    Cannabis Cannabinoid Res; 2024 Apr; ():. PubMed ID: 38683635
    [No Abstract]   [Full Text] [Related]  

  • 4. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD.
    Crombie KM; Leitzelar BN; Brellenthin AG; Hillard CJ; Koltyn KF
    Biol Psychol; 2019 Jul; 145():1-7. PubMed ID: 30978371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of exercise on circulating endocannabinoid levels-a protocol for a systematic review and meta-analysis.
    Bristot V; Poletto G; Pereira DMR; Hauck M; Schneider IJC; Aguiar AS
    Syst Rev; 2022 May; 11(1):98. PubMed ID: 35585640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.
    Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels.
    Brellenthin AG; Crombie KM; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2017 Aug; 49(8):1688-1696. PubMed ID: 28319590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.
    Bedse G; Hartley ND; Neale E; Gaulden AD; Patrick TA; Kingsley PJ; Uddin MJ; Plath N; Marnett LJ; Patel S
    Biol Psychiatry; 2017 Oct; 82(7):488-499. PubMed ID: 28438413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Selective Breeding, Voluntary Exercise, and Sex on Endocannabinoid Levels in the Mouse Small-Intestinal Epithelium.
    Schmill MP; Thompson Z; Argueta DA; DiPatrizio NV; Garland T
    Physiol Behav; 2022 Mar; 245():113675. PubMed ID: 34929258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids and Heart Rate Variability Alterations after Exposure to Prolonged Intensive Physical Exercise of the Hellenic Navy SEALs.
    Mourtakos S; Vassiliou G; Kontoangelos K; Philippou A; Tzavellas E; Tornero-Aguilera JF; Clemente-Suárez VJ; Papageorgiou C; Sidossis LS; Papageorgiou C
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of interferon-alpha treatment on AEA and 2-AG levels.
    Zajkowska Z; Borsini A; Nikkheslat N; Russell A; Romano GF; Tomassi S; Hepgul N; Forton D; Agarwal K; Hotopf M; Mondelli V; Zunszain P; Pariante CM
    Brain Behav Immun; 2020 Nov; 90():248-258. PubMed ID: 32860939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder.
    Crombie KM; Brellenthin AG; Hillard CJ; Koltyn KF
    J Trauma Stress; 2018 Feb; 31(1):134-145. PubMed ID: 29388710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Endocannabinoids Cause the Runner's High? Evidence and Open Questions.
    Siebers M; Biedermann SV; Fuss J
    Neuroscientist; 2023 Jun; 29(3):352-369. PubMed ID: 35081831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function.
    Gray JM; Wilson CD; Lee TT; Pittman QJ; Deussing JM; Hillard CJ; McEwen BS; Schulkin J; Karatsoreos IN; Patel S; Hill MN
    Psychoneuroendocrinology; 2016 Apr; 66():151-8. PubMed ID: 26821211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced endocannabinoid signaling is modulated by intensity.
    Raichlen DA; Foster AD; Seillier A; Giuffrida A; Gerdeman GL
    Eur J Appl Physiol; 2013 Apr; 113(4):869-75. PubMed ID: 22990628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
    Thompson Z; Argueta D; Garland T; DiPatrizio N
    Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids as therapeutics for PTSD.
    Sbarski B; Akirav I
    Pharmacol Ther; 2020 Jul; 211():107551. PubMed ID: 32311373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD.
    Leen NA; de Weijer AD; van Rooij SJH; Kennis M; Baas JMP; Geuze E
    Chronic Stress (Thousand Oaks); 2022; 6():24705470221107290. PubMed ID: 35707677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.